The Triangle’s story has always been rooted in innovation. While many Sun Belt markets have relied heavily on migration or tourism, Raleigh’s expansion continues to be anchored by its concentration of universities, technology firms, advanced manufacturing, health care, and life sciences.
The region’s largest real estate story has shifted from focusing almost entirely on life sciences (labs) to the transformation that manufacturing investment at large (factories) will bring to the state—a total which is now estimated to be near $140 billion per Industrial Sage. The continued buildout of major commitments from large healthcare and technology firms, and other semiconductor, life sciences, and advanced manufacturing users—is reshaping the region’s economic base and creating a longer runway for office, industrial, and residential demand. In April 2026, a large pharmaceutical company chose Durham for a $1.4 billion, 185-acre campus.
Research Triangle Park’s RTP 3.0 initiative is simultaneously repositioning one of the nation’s most important innovation districts into a more mixed-use environment with residential, retail, and amenity components.
The office and life sciences sectors are transforming. With a normal office vacancy rate of 7 to 8 percent (for multiple years pre-pandemic), the current 21.5 percent rate is hard to digest, especially since it has been flat at this level since H2 2024. Likewise, life sciences vacancy is at 26.4 percent, though it is slightly down from its 29.5 percent peak and 28 percent one year ago. The good news for both sectors is that construction is nonexistent. On the office side, in five of the last eight quarters, office absorption has been positive, and there are 3.1 million square feet of tenant requirements in the market. Tenant demand remains concentrated in newer, highly amenitized properties across Cary, West Raleigh, and Six Forks. Top-tier rents across the Triangle average $37.37/square foot, 18.3 percent above the market average ($31.60/square foot). On the life sciences side, RTP has emerged as a premier pharmaceutical manufacturing hub, leveraging its highly educated workforce and competitive labor costs to attract substantial investment from leading pharmaceutical companies. While the vacancy rate remains elevated, existing inventory is increasingly positioned to attract demand from adjacent sectors, including technology, advanced manufacturing, and other knowledge-based industries.
Capital markets are cautious but beginning to reflect that improving outlook. Office investment activity strengthened by 10.6 percent in 2026, highlighted by the $206.7 million acquisition of Bloc83, one of the largest office transactions in the region since before the pandemic. This puts year-to-date investment in office on par with the annual total for 2025. Retail and alternatives are reaching levels associated with last year’s annual total, a trendline that could allow the market to exceed last year’s level by 23 percent if continued through the final months of the year. Investors remain selective, but confidence in Raleigh/Durham has improved.
The multifamily market is also finding firmer footing after absorbing one of the largest construction waves in its history. Since 2023, more than 29,000 units have been delivered across the region, but vacancy is falling as demand remains robust. Vacancy was 9.4 percent in 3Q 2026, down over 200 basis points from a year earlier, as net absorption exceeded deliveries by more than 150 percent in the last four quarters. Household formation in Raleigh/Durham is among the strongest nationally. As a result, rent growth appears to be accelerating, and reached 1.6 percent in 3Q 2026.
The next chapter for Raleigh/Durham will likely be defined not by population growth alone, but by the cumulative impact of multibillion-dollar investments in talent, research, infrastructure, and advanced industries that continue to deepen the region’s competitive advantage.
—Cushman & Wakefield
